Submit Content

Please check your e-mail for a link to activate your account.

Global Pharmaceutical Excipient Market Worth US$ 7,415.2 Mn by 2021 : PMR

According to a latest market report published by Persistence Market Research, titled “Global Market Study on Pharmaceutical Excipients: Increased Drug Demand in Emerging Asia Pacific Market to Fuel Demand Multi-Functional Excipients”, revenue from the global pharmaceutical excipients market is expected to expand at a CAGR of 6.7% during the forecast period 2015 - 2021.

 

In the report, the global pharmaceutical excipients market is analyzed on the basis of chemistry type (i.e. source of origin), application type, functionality, and region. Based on chemistry type, the overall market has been segmented into plant-based, animal-based, mineral-based and synthetically derived excipients. Based on functionality, the market has been segmented into binders (binders, coatings, and fillers), glidents, diluents, disintegrants, and others (solvents, co-solvents, anti-microbial agents, lubricants, colorants, emulsifiers, and humectants). By application type, the market has been segmented into oral, topical, parenteral formulations, and others, which includes suppositories, intra-muscular, and ophthalmic preparations. In the overall market, oral solid dosage formulations are expected to witness increased uptake owing to the ease of consumption by patients globally. Accordingly, oral application type segment is expected to witness value increase from US$ 3,327.8 Mn in 2015 to US$ 5,094.2 Mn by the end of 2021.

 

The prime drivers of the market include rising demand for sustained-release and controlled-release formulations, especially in oral applications, and increased demand for generics. Sustained and extended release formulations are gaining popularity as they help in maintaining patient-safety through reduced number of medicine dosages, but having increased drug efficacy. Apart from these factors, increase in the incidence of chronic diseases across regions has been spurring demand for essential drugs, which is expected to fuel demand for excipients over the forecast period.

 

Frequent physical audits of excipients manufacturing facilities by officials from regulatory agencies lead to the imposition of substantial operating cost burdens on excipient manufacturers, thus hampering revenue growth for excipients over the forecast period. Other market deterrents include long gestation period before a novel excipient is formally accepted in the industry. However, the situation is expected to improve over the next few years, with individual economies formulating their own good manufacturing and good distribution practice guidelines in collaboration with the International Pharmaceutical Excipient Council.

 

Based on regions, the market has been divided into North America, Latin America, Europe, Asia-Pacific, and the MEA. Developed pharmaceutical markets such as the U.S. and EU are expected to emerge as the main sourcing markets, while economies such as India, China, and Brazil are expected to emerge as the main supplying countries for raw materials such as cellulose, starch, lactose, etc.

 

Formalization of good manufacturing practices for excipients is an urgent need in the global excipients market, in order to cater to rising demand for higher purity excipients in applications such as parenteral forms. According to various trade associations and regulatory agencies, global acceptance of excipients by drug manufacturers is a relatively lengthy process, which takes around seven to 10 years. This factor is expected to prolong the revenue conversion period for excipients manufacturers.

 

Request Sample Report: http://www.persistencemarketresearch.com/samples/4421

 

This report assesses trends by chemistry type, application type, functionalities and regions to offer analytical insights about the potential demand emerging for particular pharmaceutical excipients in specific regions. North America is estimated to dominate the pharmaceutical excipients market accounting for a maximum revenue share of the overall market by the end of 2015. By 2021 end, North America and Europe markets are expected to account for over three-fifth share of the global pharmaceutical excipients market revenue. In terms of market share by value, North America is estimated to retain its dominant position, registering a CAGR of 6.9% over the forecast period.

 

View Detail Report With TOC: http://www.persistencemarketresearch.com/market-research/pharmaceutical-excipients-market.asp

 

Some key companies covered in this report include BASF SE, Evonik Industries AG, Innophos Holdings Inc., The Lubrizol Corporation, The Dow Chemical Company, Wacker Chemie AG, and Ashland Inc. These companies are primarily focused on enhancing their product portfolio through research and development and the introduction of innovative and cost-effective advanced manufacturing procedures such as co-processing of existing excipients in order to gain higher market share and to strengthen their respective positions in the global market.

 

For more Info: http://www.persistencemarketresearch.com/contact-us.asp

 

About Us:

Persistence Market Research (PMR) is an innovative provider of market research reports and consulting services. The three PMR pillars of strength that have helped us win clients for years are: Quality Research, Quick Research, and In-depth Research.

 

PMR’s team of seasoned analysts and consultants are experts in their domain. At PMR, we process complex, exhaustive primary and secondary research data into valuable insight. We Understand that each client has a unique problem statement, and address it with our strengths.

 

Contact:

Persistence Market Research

305 Broadway

7th Floor, New York City,

NY 10007, United States,

USA - Canada Toll Free: +1 800-961-0353

Email: sales@persistencemarketresearch.com

Web: http://www.persistencemarketresearch.com


Soy Lecithin Market Shares, Strategies and Forecast Worldwide, 2016 to 2026

Soy Lecithin is typically the brownish yellow complex mixture of glycolipids, phospholipids, neutral lipids and sugars. The use of Soy to produce the lecithin is the highest as compare to the other sources of lecithin. The wide functional, nutritional and therapeutic properties of soy lecithin are used in variety of application. Soy Lecithin is mostly used as emulsifier in various industrial application such as food, feed, paints, cosmetics, plastics, pharmaceutical and others. The wide and constantly increasing product category for Lecithin applications is a healthy sign for the budding demand of soy lecithin market.

Soy Lecithin Market: Drivers and Restraints

The abundant availability and low pricing in international markets makes Soy the major driver for the growth of the Soy Lecithin Market. The increasing areas of application in food as well as non-food segments of Soy lecithin is also estimated to benefit the global demand of soy lecithin market. The changing food habits and increased per capita income is driving the growth of the packaged and processed food industry which is furthermore estimated to benefit the soy lecithin market. The growing concerns towards healthy lifestyle are propelling the demand for the nutrient rich foods, beverages and supplements ultimately expected to push companies to use nutrient rich and cost effective products like soy lecithin.  The wide physical and chemical properties of Soy lecithin make it a lucrative product in paints and cosmetic industry. The maturing use of lecithin in pharmaceutical is forecasted to accelerate the demand of soy lecithin market. On the other hand the use of genetically modified soy might be the restrain factors due to the increasing awareness and inclination towards the use of organic food products.

Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-1350

Soy Lecithin Market: Segmentation

On the basis of type, the global Soy Lecithin market is segmented into:

  • Food Grade
  • Feed Grade
  • Pharmaceutical Grade
  • Industry Grade
  • Other

On the Basis of Function, the global Soy Lecithin Market is segmented into:

  • Emulsifiers
  • Nutritional supplements
  • Dispersants
  • Wetting agents
  • Viscosity modifiers
  • Release aids
  • Surfactants
  • Nutritional supplements

Visit For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1350

On the basis of Application, the global Soy Lecithin market is segmented into:

  • Food & Beverages
  • Paint Industry
  • Pharmaceutical
  • Others (Plastic and other industries)

Global Soy lecithin: Regional Analysis

The global Soy lecithin is expected to be driven by strong demand in Asia pacific region especially in regions like China and India. Asia pacific is forecasted to be the largest producer as well as consumer for the global soy lecithin market by volume as well as by value. Another major market for the Soy Lecithin market is Latin America, primarily driven by growth in food and beverages industry. Europe is also forecasted to be the significant contributor for the demand of Soy Lecithin followed by Latin America. Africa is forecasted to grow at a steady rate but the fast growing economies are considered to be a major driving factor in the demand of Soy lecithin in proximate future.

Full Report Analysis@ http://www.futuremarketinsights.com/reports/soy-lecithin-market

Soy Lecithin Market: Key Players

Some of the market participants in the global are E. I. DU PONT DE NEMOURS AND COMPANY, Archer Daniels Midland Company, Cargill, Lipoid GmbH, American Lecithin Company, LASENOR EMUL, Lecico Gmbh, Ruchi Soya Industries Ltd, Ceresking Ecology & Technology Co. Ltd., Bunge Limited and others.


Market Research on Fabry Disease Market 2016 and Analysis to 2026

Fabry disease is also known as Anderson-Fabry disease and alpha-galactosidase A deficiency. It is a rare genetic disorder of lipid metabolism resulting from the deficient activity of the alpha-galactosidase A (a-Gal A) enzyme. The deficiency of the enzyme is caused by the alterations in the genes that instructs the cells to make alpha-galactosidase A (a-Gal A) enzyme. Fabry disease is known to cause variety of systemic symptoms and complications, one of them being metabolic disorders. The metabolism of sphingolipids is minimized, in fabry disease which results in the multiple organ failure and death. Owing to the deficiency of alpha galactosidase A enzyme, glycolipid called Gb3 accumulates in the blood vessels and other organs and thus results in formation of blockage or clots that leads to malfunctioning of the system.

Fabry Disease Market: Drivers and Restraints

The major drivers that drive the fabry disease market growth are extensive R&D activities, adoption of advanced technologies in the research practices. Due to hereditary nature and severity of the disease, complications in physiological systems, such as cardiac system, urinary system and others are expected to increase the demand for trustworthy treatment. Extensive R&D practices is one of the valuable drivers of the market. Due to this, various therapeutic products, such as, PRX-102, JR-051, NP-003, GC-1119 and others, are under pipeline studies. However, rare incidence rate (1 in 40,000), lack of awareness about advancements in genetic sciences, technological limitations in certain region of the world are some of the restraining factors that may affect the growth of the fabry disease market.

Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-1365

Fabry Disease Market: Segmentation

The global fabry disease market has been classified on the basis of treatment, end use and geography.

Based on treatment, the global fabry disease market is divided into following:

  • Enzyme replacement therapy
  • Gene therapy
  • Pharmaceutical formulations containing agalsidase alpha
  • Analgesics
  • Anticonvulsants
  • NSAIDs

Based on end user type, the global fabry disease market is divided into following:

  • Hospitals
  • Clinics

Visit For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1365

Fabry Disease Market: Overview

The enzyme replacement therapy is designed to provide enzyme to the patients suffering from enzyme deficiency. It was found that this treatment was not a complete cure though it improved the metabolism. Enzyme replacement therapy is the most expensive and unaffordable treatment among the treatments for fabry disease, hence the market for enzyme replacement therapy is expected to register moderate growth in overall fabry disease market. The analgesics, anticonvulsants and NSAIDs are generally known for the treatment of pain and other symptoms associated with fabry disease hence, contributing majorly to the market.

Fabry Disease Market: Regional Overview

Geographically, the global fabry disease market is classified into regions namely, North America, Latin America, Western Europe, Eastern Europe, APAC, Japan, Middle East and Africa. North America is estimated to be the most lucrative region owing to the affordability of the treatment followed by Europe. The rare incidences in APAC and MEA countries are expected to limit the growth of fabry disease market in these regions.

Full Report Analysis@ http://www.futuremarketinsights.com/reports/fabry-disease-market

Fabry Disease Market: Key Players

The major players operating in this market and involved in development of new medications include Sanofi-Aventis LLC, iBio, Inc., GlaxoSmithKline plc, Genzyme Corporation, and Neuraltus Pharmaceuticals, Inc. Some of the existing key players in the global fabry disease market are Novartis Pharmaceuticals, Merc & Co., Inc., Bristol-Myers Squibb Company, AbbVie Inc., Amgen Inc., Teva pharmaceutical Industries Ltd., Pfizer Inc., Takeda Pharmaceutical Co. Ltd.


Hepatocellular Carcinoma HCC Treatment Market to Make Great Impact In Near Future by 2026

Hepatocellular carcinoma (HCC) is also known as malignant hepatoma. HCC is the major malignancy of the liver and is found to occur mainly in patients with chronic liver diseases and cirrhosis. The cells of origin of HCC are the hepatic stem cells, although this remains the subject of investigation. The hepatic tumors proliferates with local expansion, spreading in intrahepatic region and finally distant metastases. The uncommon hepatocellular carcinoma is anticipated to witness rise in incidence rate during the forecast period. HCC is currently expected to be the third leading cause of death worldwide. In the past, HCC generally occurred at an advanced stage of decompensated liver disease or cirrhosis. The technological advancements and the routine liver function tests are now resulting in the early detection of hepatocellular carcinoma. The increase in incidences of hepatocellular carcinoma associated with hepatitis C virus are expected to grow the hepatocellular carcinoma treatment market during the forecast period.

Hepatocellular Carcinoma (HCC) Treatment Market: Drivers and Restraints

The incidence rate of hepatic cancer such as intrahepatic bile duct cancer in U.S. was approximately 39,230 during 2015. The risk factors associated with hepatocellular carcinoma are Hepatitis B virus (HBV) infection and hepatitis C virus (HCV) infection, alcoholic cirrhosis, metabolic syndrome, biliary cirrhosis, and chronic liver injury. The advancement in technology, personalized medicine, cost effective treatment procedures are few other factors predicted to keep up the growth of global hepatocellular carcinoma treatment market. However, side effects associated with the chemotherapy, high cost of treatment are some of the major restraints limiting the growth of global hepatocellular carcinoma treatment market.

Browse Full Report@ http://www.futuremarketinsights.com/reports/hepatocellular-carcinoma-hcc-treatment-market

Hepatocellular Carcinoma (HCC) Treatment Market: Segmentation

The global hepatocellular carcinoma (HCC) treatment market has been segmented on the basis of application, end use and geography.

Based on application, the global hepatocellular carcinoma (HCC) treatment market is segmented into:

  • Brachytherapy
  • Chemotherapy
  • Local Ablation Therapy

Based on end user type, the global hepatocellular carcinoma (HCC) treatment market is segmented into:

  • Hospitals
  • Clinics
  • Cancer rehabilitation centers

Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-1370

Hepatocellular Carcinoma (HCC) Treatment Market: Overview

Inventions in technologies for cancer treatment procedures are expected to launch into the market in the forecast period. Moreover, the increasing investment of pharmaceutical companies in the research and development of anticancer drugs would contribute to the growth of hepatocellular carcinoma treatment market. Monoclonal antibodies and other immunological treatments are generally known for their lesser side effects and better efficacy.

Hepatocellular Carcinoma (HCC) Treatment Market: Regional Overview

Geographically, the global Hepatocellular Carcinoma (HCC) treatment market is classified into regions namely, North America, Latin America, Western Europe, Eastern Europe, APEJ, Japan, Middle East and Africa.Hepatitis B virus (HBV) infection and hepatitis C virus (HCV) infections are found to be the most significant cause of hepatocellular carcinoma. Chronic HBV infection is the principal cause of hepatocellular carcinoma in Asia and Africa. HCV infection is the principal cause of hepatocellular carcinoma in North America, Europe, and Japan. The global hepatocellular carcinoma treatment market is expected to grow in future due to increasing investment by multinational companies in the cancer research.

Download TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1370

Hepatocellular Carcinoma (HCC) Treatment Market: Key Players

Bayer AG is one of the leading provider of hepatocellular carcinoma (HCC) treatment drugs. Some of the key players in hepatocellular carcinoma treatment market are Novartis Pharmaceuticals, Merck & Co., Inc., Bristol-Myers Squibb Company, AbbVie Inc., Johnson & Johnson Pvt. Ltd., Celgen Corporation, Amgen Inc., Teva pharmaceutical Industries Ltd., Pfizer Inc., and Takeda Pharmaceutical Co. Ltd. These companies focuses on the priority areas of the antiviral and oncology in order to address unmet medical needs.


Global Household Insecticides Market is Expected to Grow US$ 17,249 Mn by 2021 : PMR

According to a latest market report published by Persistence Market Research titled, “Global Market Study on Household Insecticides Market: Asia Pacific to Witness Highest Growth by 2021”, the global household insecticides market has been estimated to be valued at US$ 10,958.0 Mn in 2015 and is expected to expand at a CAGR of 7.9% over 2015–2021, to reach US$ 17,249.0 Mn by 2021.

 

Household insecticides include substances applied to clothing, skin, or other surfaces to control or repel insects. A wide range of insecticides is currently available in the global market. These include insect sprays for use in the kitchen to weed killers for the lawn and mosquito repellents for indoor or outdoor use. Household insecticides have been witnessing wide acceptance to keep homes and gardens insect-free and to ensure safe and healthy living environment

 

The growth of the global household insecticides market is majorly driven by increasing demand from emerging regions such as Asia Pacific due to rapid urbanization and growing disposable income among the population. In addition, factors such as rising urbanization and concerns over vector-borne diseases across the globe are projected to fuel demand for household insecticides in the near future.

 

Conversely, toxicity levels in household insecticides are increasing (primarily due to the growing immunity level of insects), which is causing health problems from prolonged exposure to chemicals and odor. This is one of the primary factors expected to hamper demand for household insecticides globally.

 

Revenue from the global household insecticides market has been estimated to increase from US$ 10,958.0 Mn in 2015 to US$ 17,249.0 Mn by 2021 at a CAGR of 7.9%.

 

The global household insecticides market has been broadly segmented on the basis of purpose, distribution channel, packaging, composition, and region. On the basis of purpose, the global household insecticides market has been segmented into: mosquito & flies control segment (sub-segments include aerosol/spray, electric, coils, and others); rat & rodent control segment (sub-segments include aerosol/spray and baits); termite control segment (sub-segments include aerosol/spray and others); bedbugs & beetles control segment (sub-segments include aerosol/spray and others); and others segment (sub-segments include aerosol/spray and others). On the basis of the distribution channel, the market is segmented into online and offline channels. The offline channel segment is further sub-segmented into a hypermarket, supermarket, drug stores, convenience stores, neighborhood stores and others. Others sub-segment includes specialty and other traditional stores. On the basis of packaging, the market has been segmented into three types: small (50 ML– 200 ML), medium (200 ML– 500 ML), and large (500 ML and above). On the basis of composition, the market is segmented into natural and synthetic. The synthetic channel segment is further sub-segmented as N,N-Diethyl-meta-Toluamide (DEET), Hydroxyethyl Isobutyl Piperidine Carboxylate (Picaridin), and others. The natural segment is further sub-segmented as Citronella Oil, Geraniol, and Others. Finally, on the basis of region, the global household insecticides market is segmented into North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.

 

Revenue from the mosquito and flies control segment is expected to remain dominant owing to increasing demand for these insecticides in developing countries due to growing health concerns. Major players in this market are focused on developing eco-friendly products containing natural ingredients.

 

Request Sample Report: http://www.persistencemarketresearch.com/samples/3923

 

Asia Pacific has been estimated to account for the significant market share of 54.6% in 2015. Also, it is expected to record the highest growth during the forecast period due to greater demand owing to rapid urbanization and increasing awareness regarding home pest control in countries such as India and China.

 

View Detail Report With TOC: http://www.persistencemarketresearch.com/market-research/household-insecticides-market.asp

 

Godrej Consumer Products Ltd., Reckitt Benckiser Group, SC Johnson, Spectrum Brands Holdings, Earth Chemicals Co. Ltd., Jyothy Laboratories Ltd., and Dabur India Limited are some of the leading players in the global household insecticides market. Other major players include AMPLECTA Europe GmbH VIN Corporation and Jaico R.D.P. N V.

 

For more Info: http://www.persistencemarketresearch.com/contact-us.asp

 

About Us:

Persistence Market Research (PMR) is an innovative provider of market research reports and consulting services. The three PMR pillars of strength that have helped us win clients for years are: Quality Research, Quick Research, and In-depth Research.

 

PMR’s team of seasoned analysts and consultants are experts in their domain. At PMR, we process complex, exhaustive primary and secondary research data into valuable insight. We Understand that each client has a unique problem statement, and address it with our strengths.

 

Contact:

Persistence Market Research

305 Broadway

7th Floor, New York City,

NY 10007, United States,

USA - Canada Toll Free: +1 800-961-0353

Email: sales@persistencemarketresearch.com

Web: http://www.persistencemarketresearch.com


Gum Hydrocolloid Market 2015-2025 Shares, Trend and Growth Report

The global gum hydrocolloids market has been significantly growing due to the rise in demand for healthy and natural food products by consumers of different age group. Hydrocolloid is a substance which forms gel like medium in the presence of water. It is also defined as a colloidal system, in which the colloid particles are dispersed in water. Hydrocolloid are widely used within food industry for various purposes such as for gelling, thickening, foaming, coating, film-forming, improving bake-stability, improving freeze-thaw stability and encapsulation. In addition, it is also used in food products such as jams, soups, ice-creams, jellies, cakes & candies, gelled desserts in order to create the desired texture of food. The major advantages associated with gum hydrocolloid are its ability to modify the flow behavior/viscosity of food systems.

Gum Hydrocolloid Market: Drivers and Restraints

The gum hydrocolloid market is largely driven by growing research and development in hydrocolloid ingredients. Also, increase in consumer preference for natural ingredients in food and beverages are major factor driving the gum hydrocolloid market globally. However, uneven supply of raw material, high price volatility in raw material are anticipated to hamper the market growth during the forecast period.

Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-596

Gum Hydrocolloid Market: Segmentation

Gum hydrocolloid market is segmented on the basis of type, function, application and by region. On the basis of type the gum hydrocolloid market is segmented into gellan gum, guar gum, gum Arabic, locust bean gum and xanthan gum. Furthermore, on the basis of function the market is segmented into thickener agent, gelling agent, and stabilizing agent. On the basis of application the gum hydrocolloid market can be segmented as bakery, confectionary, meat and poultry processing, dairy products, sauces and dressing, cosmetics and pharmaceuticals. Lastly, on the basis of region the gum hydrocolloid market is segmented into North America, Latin America, Western Europe, Eastern Europe, Asia Pacific, Japan and Middle East and Africa.

Gum Hydrocolloid Market: Key Players

Some of the leading companies operating in gum hydrocolloid market are Archer Daniels Midland Company (ADM), Cargill Inc., Royal DSM, Kerry Group PLC, Danisco A/S, E. I. Du Pont De Nemours And Company to name a few. Major companies dealing in gum hydrocolloid market are focused towards acquisition and launch of new product to modify and upgrade their product portfolio.

Visit For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-596

Gum Hydrocolloid Market: Regional Overview

Among all the regions North America was the largest market for gum hydrocolloid in 2013 followed by Europe and Asia Pacific. Developing countries such as India and China are anticipated to witness a high growth in demand for gum hydrocolloid market due to changing lifestyle of consumers coupled with increase in awareness towards healthy living is fuelling the market growth. Sudan is one the major producer of all major gum Arabic in the world with having more than 80% of global productivity. Since gum Arabic is widely used in soft drink industry, US has exempted it from broad trade ban which was imposed in 1997. This lift from ban allowed Sudan to maintain its position as a world power in gum Arabic market.


New Trends of Feed Premix Market with Worldwide Industry Analysis to 2025

Feed premix generally refers to enriched mixtures of biologically dynamic substances that are synthesized chemically and microbiologically to increase the nutritious value of feeds in order to improve its effect on farm animals while preventing them from various health related disorder. It is a substance that is mixed with two or more ingredients during early stages of the manufacturing process of animal feed compound. The various advantages of feed premix includes improving appetite, digestion, and feed intake of animals. It also helps in enhancing immune system by increasing antibody titres and also augments the antibiotic growth in the animal’s body. However, lack of flexibility in diet formulation and lack of knowledge about the quality of the supplemental ingredients to be used in feed premix are some of the disadvantages for this market.

Feed Premix Market: Drivers and Restraints

The major driving factors for feed premix market includes increasing meat consumption across the globe, mass production of meat coupled with rising demand for quality meat. Increasing awareness among the farmers about the benefits of feed ingredients is expected to boost the growth of feed premix industry in the global market. However, rising raw material cost and lack of awareness about the premix is obstructing the market growth of feed premix market globally. The shift in consumption from red meat to white meat in developed as well as developing countries coupled with technology advancement and methods for manufacturing feed premix with high expertise translates to major trend in global feed premix market.

Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-592

Feed Premix Market: Segmentation

Global feed premix market is segmented on the basis of ingredients, livestock and region. On the basis of product feed premix market is segmented into vitamins, minerals, amino acids, antibiotics, antioxidants and others. Furthermore, on the basis of livestock the feed premix market is segmented into ruminants, poultry, swine, aquatic animals, cattle, sheep-goat and other animals. Lastly, on the basis of region the market is segmented into North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan and Middle East & Africa.

Feed Premix Market: Region-wise Outlook

North America was the largest market for feed premix closely followed by Asia-Pacific in 2014. The demand for the feed premix is expected to grow in the emerging markets such as India, China and Brazil by 2025. This growth is attributed to continuous rise in demand for feed premix in the domestic market. Europe and Africa are anticipated to grow steadily due to the increasing importance for animal health and wellness in the animal husbandry industry.

Visit For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-592

Feed Premix Market: Key Players

The key players in the global feed premix market are Nutreco N.V., Cargill, Inc., Koninklijke Dsm N.V., DLG Group, Phibro Group, Archer Daniels Midland Company to name a few. The major companies are focusing towards acquisition in order to increase their consumer base by expanding their product portfolio. For instance, in 2011, Cargill Inc. acquired Provimi, the global animal nutrition company in order to offer the broadest array of animal nutrition products, services and capabilities to its global customers. Cargill Inc. feed premix products comes under different brand name such as Provimi, Akey, Vigortone, Citura, Neolait, Nutral and Nutron.


Learn details of the Fatty Liver Treatment Market Forecast and Segments, 2016-2026

Fatty liver disease is the most common liver dysfunction in which the triglyceride fat accumulates in liver cells. The fatty liver disease is caused due to obesity and excessive alcohol intake. Fatty liver is caused due to excessive alcohol intake known as Alcoholic Fatty Liver Disease (ALD) and obesity or insulin resistance known as Non-Alcoholic Liver Disease (NAFLD). The major risk factors associated with fatty liver disease are alcoholic cirrhosis, metabolic syndrome, biliary cirrhosis, progressive liver fibrosis and hepatocellular carcinoma (HCC) as well as increased cardiovascular disorder. Fatty liver disease is currently expected to be the leading cause of hepatocellular carcinoma. The technological advancements and the routine liver function tests are now resulting in the early detection of fatty liver treatment. The increase in incidence of fatty liver disease associated with excessive alcohol intake is expected to create an opportunity for the growth of fatty liver treatment market during the forecast period.

Fatty Liver Treatment Market: Drivers and Restraints

The incidence rate of fatty liver disease particularly the Non-Alcoholic Liver Disease (NAFLD) was estimated to increase approximately by 20 to 25% in 2015. Thus, the market for fatty liver treatment is anticipated to grow significantly during the forecast period. The advancement in technology, personalized medicine, cost effective treatment procedures are few other factors predicted to fuel growth of global fatty liver treatment market. However, the side effects associated with the treatment, and increasing stringency in the regulatory requirements are some of the major factors limiting the growth of global fatty liver treatment market.

Browse Full Report@ http://www.futuremarketinsights.com/reports/fatty-liver-treatment-market

Fatty Liver Treatment Market: Segmentation

The global fatty liver treatment market has been classified on the basis of drugs, end use and geography.

Based on drugs, the global fatty liver treatment market is divided into following:

  • Thiazolidinedione
  • Vitamin E
  • Metformin
  • Statins
  • Polyunsaturated fatty acids
  • Angiotensin receptor blockers
  • Pentoxifylline

Based on end user type, the global fatty liver treatment market is divided into following:

  • Hospitals
  • Clinics

Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-1369

Fatty Liver Treatment Market: Overview

Due to the availability of variety of agents for fatty liver treatment, the market for overall fatty liver treatment is expected to grow significantly. Additionally, the investment of pharmaceutical companies in the research and development are anticipated to contribute in the growth of fatty liver treatment market. In U.S. it is estimated that more than 15 Mn people are involved in the abuse or over abuse of alcohol and among them more than 90% people suffer from fatty liver disease. Thiazolidinedione and metformin are widely used for the Non-Alcoholic Liver Disease (NAFLD) caused due to insulin resistance. Thus, thiazolidinedione and metformin are expected to highly contribute in the growth of global fatty liver treatment market.

Fatty Liver Treatment Market: Regional Overview

Geographically, the global fatty liver treatment market is classified into regions namely, North America, Latin America, Western Europe, Eastern Europe, APAC, Japan, Middle East and Africa. North America and Europe are expected to dominate the fatty liver treatment market due to abuse cases of alcoholic beverages. APAC is the fastest growing market with increasing prevalence of fatty liver disease associated with factors such as growing alcoholic intake, drug abuse and high prevalence of diabetes.  The global fatty liver treatment market is expected to grow remarkably during the forecast period due to increasing investment by multinational companies in the research and development.

Download TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1369

Fatty Liver Treatment Market: Key Players

Some of the key players operating in this market are Cardax, Inc., Daewoong Co., Ltd., Hoffmann-La Roche Ltd., Glenmark. GW Pharmaceuticals, Limerick BioPharma, Inc., Merck & Co., Inc., Novartis AG, Orchid Chemicals & Pharmaceuticals Ltd, AstraZeneca.


Learn details of the Fatty Liver Treatment Market Forecast and Segments, 2016-2026

Fatty liver disease is the most common liver dysfunction in which the triglyceride fat accumulates in liver cells. The fatty liver disease is caused due to obesity and excessive alcohol intake. Fatty liver is caused due to excessive alcohol intake known as Alcoholic Fatty Liver Disease (ALD) and obesity or insulin resistance known as Non-Alcoholic Liver Disease (NAFLD). The major risk factors associated with fatty liver disease are alcoholic cirrhosis, metabolic syndrome, biliary cirrhosis, progressive liver fibrosis and hepatocellular carcinoma (HCC) as well as increased cardiovascular disorder. Fatty liver disease is currently expected to be the leading cause of hepatocellular carcinoma. The technological advancements and the routine liver function tests are now resulting in the early detection of fatty liver treatment. The increase in incidence of fatty liver disease associated with excessive alcohol intake is expected to create an opportunity for the growth of fatty liver treatment market during the forecast period.

Fatty Liver Treatment Market: Drivers and Restraints

The incidence rate of fatty liver disease particularly the Non-Alcoholic Liver Disease (NAFLD) was estimated to increase approximately by 20 to 25% in 2015. Thus, the market for fatty liver treatment is anticipated to grow significantly during the forecast period. The advancement in technology, personalized medicine, cost effective treatment procedures are few other factors predicted to fuel growth of global fatty liver treatment market. However, the side effects associated with the treatment, and increasing stringency in the regulatory requirements are some of the major factors limiting the growth of global fatty liver treatment market.

Browse Full Report@ http://www.futuremarketinsights.com/reports/fatty-liver-treatment-market

Fatty Liver Treatment Market: Segmentation

The global fatty liver treatment market has been classified on the basis of drugs, end use and geography.

Based on drugs, the global fatty liver treatment market is divided into following:

  • Thiazolidinedione
  • Vitamin E
  • Metformin
  • Statins
  • Polyunsaturated fatty acids
  • Angiotensin receptor blockers
  • Pentoxifylline

Based on end user type, the global fatty liver treatment market is divided into following:

  • Hospitals
  • Clinics

Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-1369

Fatty Liver Treatment Market: Overview

Due to the availability of variety of agents for fatty liver treatment, the market for overall fatty liver treatment is expected to grow significantly. Additionally, the investment of pharmaceutical companies in the research and development are anticipated to contribute in the growth of fatty liver treatment market. In U.S. it is estimated that more than 15 Mn people are involved in the abuse or over abuse of alcohol and among them more than 90% people suffer from fatty liver disease. Thiazolidinedione and metformin are widely used for the Non-Alcoholic Liver Disease (NAFLD) caused due to insulin resistance. Thus, thiazolidinedione and metformin are expected to highly contribute in the growth of global fatty liver treatment market.

Fatty Liver Treatment Market: Regional Overview

Geographically, the global fatty liver treatment market is classified into regions namely, North America, Latin America, Western Europe, Eastern Europe, APAC, Japan, Middle East and Africa. North America and Europe are expected to dominate the fatty liver treatment market due to abuse cases of alcoholic beverages. APAC is the fastest growing market with increasing prevalence of fatty liver disease associated with factors such as growing alcoholic intake, drug abuse and high prevalence of diabetes.  The global fatty liver treatment market is expected to grow remarkably during the forecast period due to increasing investment by multinational companies in the research and development.

Download TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1369

Fatty Liver Treatment Market: Key Players

Some of the key players operating in this market are Cardax, Inc., Daewoong Co., Ltd., Hoffmann-La Roche Ltd., Glenmark. GW Pharmaceuticals, Limerick BioPharma, Inc., Merck & Co., Inc., Novartis AG, Orchid Chemicals & Pharmaceuticals Ltd, AstraZeneca.


Lithium Fluoride Market: Global Industry Analysis and Forecast 2016 - 2022

The developing in the glass, optics and electronic and electrical industries has initiated a high demand for Lithium and related compounds. Lithium and lithium based compounds are one the key substances that have dynamic usage, either as a feedstock or as product. One of the most commercially important compound is Lithium fluoride. Lithium fluoride is an odorless, crystalline lithium salt manufactured by the reaction of lithium hydroxide with hydrogen fluoride. Alternatively it is also manufactured by dissolving lithium carbonate in excess hydrogen fluoride and dehydrating it by heating until redness appears. Lithium fluoride is highly stable and has a low melting point which is why it is used an ingredient in molten salt chemistries and liquid fluoride nuclear reactor. Owing to its stable ionic structure lithium fluoride find extensive usage as a heat sink material and fluxing agent in ceramics, enamel and glass industry .It is also used for welding, soldering and dip brazing fluxes. However the handling and the reactivity of Lithium fluoride has to be kept in consideration due to the development of toxic hydrogen fluoride gas, when lithium fluoride comes in contact with mineral acids.

 

The lithium fluoride market is driven by the extensive demand from glass industry and demand for nuclear power generation. The lithium fluoride market is thus anticipated to exhibit double digit growth owing to the increase in nuclear energy based applications for the electricity generation. With significant development in the development in the technologies of hybrid and electric based cars, the demand for lithium fluoride based batteries has escalated significantly thus giving a boost to the lithium fluoride market. The use of lithium fluoride as an analysis crystal in pharmaceutical application such as X-ray imaging could be a potential market opportunity in the lithium fluoride market. Additionally high demand from molten salt application and metallurgical operations is anticipated to further drive the lithium fluoride market. However the lithium fluoride market is restrained due to the presence stringent environmental laws in different regions and also due to high level toxicity.

 

The lithium fluoride market is be segmented on the basis of regions—North America, Latin America, APEJ, Japan, Western Europe, Eastern Europe and Middle East & Africa. North America and APEJ are one of the largest consumer in the lithium fluoride market owing to the extensive demand of lithium fluoride in the manufacture of ceramics, glass and enamels. The major lithium fluoride market in the APEJ regions are China and India. The lithium fluoride market in these regions is driven by extensive demand for lithium molten salt in salt chemistries and heat sink materials. Likewise the lithium fluoride market in Japan is anticipated to exhibit similar growth and trend patterns. The extensive application of lithium fluoride in optical imaging and pharmaceutical applications has boosted the Lithium fluoride market in the Western and Eastern Europe. However due to the presence of environmental regulation and alternative technologies in North America and Western Europe the growth in during the forecast period is anticipated to be modest. Latin America and Middle East & Africa are anticipated to exhibit a strong growth during the forecast period owing to the extensive metallurgical application in these regions.

 

Interested in report: Please follow the below the links to meet your requirements; Request for the Report Brochure: http://www.persistencemarketresearch.com/samples/10175

 

Some of the prominent players among may others included in the lithium fluoride market report are Crystran Ltd., FMC, Rockwood, Leverton Clarke, Axiom Chemicals Pvt. Ltd.,, Jiangxu Ganfeng Lithium, Harshil Fluoride Brivo Lithium, Eagle Picher Technologies LLC and Huizhi Lithium Energy

 

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.

 

Request TOC (table of content), Figures and Tables of the Report: http://www.persistencemarketresearch.com/toc/10175

 

The report covers exhaustive analysis on:

  • Lithium Fluoride Market Segments

  • Lithium Fluoride Market Dynamics

  • Historical Actual Market Size, 2012 - 2014

  • Lithium Fluoride Market Size & Forecast 2015 to 2025

  • Supply & Demand Value Chain

  • Lithium Fluoride Market Current Trends/Issues/Challenges

  • Competition & Companies involved

  • Technology

  • Value Chain

  • Lithium Fluoride Market Drivers and Restraints

 

Regional analysis for Lithium Fluoride Market includes

  • North America

  • Latin America

  • Europe

  • Asia Pacific & Japan

  • The Middle East and Africa

 

Report Highlights:

  • Shifting Industry dynamics

  • In-depth market segmentation

  • Historical, current and projected industry size Recent industry trends

  • Key Competition landscape

  • Strategies of key players and product offerings

  • Potential and niche segments/regions exhibiting promising growth

  • A neutral perspective towards market performance

 

For more Info: http://www.persistencemarketresearch.com/contact-us.asp

 

Key points covered in the report

1) Report segments the market on the basis of types, application, products, technology, etc (as applicable)

2) The report covers geographic segmentation

North America

Europe

Asia

RoW

3) The report provides the market size and forecast for the different segments and geographies for the period of 2010 to 2020

4) The report provides company profiles of some of the leading companies operating in the market

5) The report also provides porters five forces analysis of the market.-

 

About Us

 

Persistence Market Research (PMR) is a full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. PMR boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients’ business needs.

 

PMR stands committed to bringing more accuracy and speed to clients’ business decisions. From ready-to-purchase market research reports to customized research solutions, PMR’s engagement models are highly flexible without compromising on its deep-seated research values.

 

Contact

 

Persistence Market Research

 

305 Broadway

 

7th Floor, New York City,

 

NY 10007, United States,

 

USA - Canada Toll Free: 800-961-0353

 

Email: sales@persistencemarketresearch.com

 

Web: http://www.persistencemarketresearch.com



connect